EBA
ABBV icon

Eagle Bay Advisors’s AbbVie ABBV Stock Holding History

Eagle Bay Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
8,312
+81
+1% +$17.4K 1.57% 16
2026
Q1 		$1.79M Buy
8,231
+112
+1% +$24.8K 1.58% 17
2025
Q4 		$1.86M Sell
8,119
-409
-5% -$93.2K 1.35% 15
2025
Q3 		$1.97M Sell
8,528
-906
-10% -$184K 1.55% 14
2025
Q2 		$1.75M Sell
9,434
-48
-0.5% -$8.92K 1.45% 15
2025
Q1 		$1.99M Sell
9,482
-33
-0.3% -$6.42K 1.68% 14
2024
Q4 		$1.69M Sell
9,515
-206
-2% -$37.9K 1.06% 18
2024
Q3 		$1.92M Buy
9,721
+7
+0.1% +$1.31K 0.74% 28
2024
Q2 		$1.67M Buy
9,714
+378
+4% +$62.6K 1.01% 19
2024
Q1 		$1.7M Sell
9,336
-534
-5% -$92K 1.07% 19
2023
Q4 		$1.53M Sell
9,870
-385
-4% -$56.1K 0.97% 22
2023
Q3 		$1.53M Buy
10,255
+441
+4% +$64.7K 0.71% 31
2023
Q2 		$1.32M Sell
9,814
-22
-0.2% -$3.23K 0.76% 31
2023
Q1 		$1.57M Sell
9,836
-429
-4% -$65.6K 0.86% 26
2022
Q4 		$1.66M Sell
10,265
-1,233
-11% -$189K 0.93% 24
2022
Q3 		$1.54M Sell
11,498
-292
-2% -$41.9K 0.95% 21
2022
Q2 		$1.81M Buy
11,790
+329
+3% +$50.3K 1.09% 16
2022
Q1 		$1.86M Buy
11,461
+128
+1% +$18.6K 1.52% 13
2021
Q4 		$1.53M Sell
11,333
-2,476
-18% -$292K 0.98% 16
2021
Q3 		$1.49M Buy
13,809
+2,171
+19% +$248K 0.84% 20
2021
Q2 		$1.32M Buy
+11,638
New +$1.31M 1.07% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Eagle Bay Advisors's ABBV Position: Q2 2026 in Review

Eagle Bay Advisors increased its AbbVie (ABBV) stake by 0.98% in Q2 2026, buying an estimated $17.4K and bringing the position to 8,312 shares worth $2.09M. The position accounts for 1.57% of the portfolio, ranked #16.

Eagle Bay Advisors first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Eagle Bay Advisors held 8,312 shares of AbbVie worth $2.09M as of Q2 2026.
  • Eagle Bay Advisors bought 81 AbbVie shares in Q2 2026, an estimated $17.4K.
  • AbbVie made up 1.57% of Eagle Bay Advisors's portfolio in Q2 2026, its #16 holding.
  • Eagle Bay Advisors first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eagle Bay Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.